The heterogeneity of "major depression".
作者信息
Goldberg David
机构信息
Institute of Psychiatry, King's College, London, UK.
出版信息
World Psychiatry. 2011 Oct;10(3):226-8. doi: 10.1002/j.2051-5545.2011.tb00061.x.
Abstract
摘要
相似文献
1
The heterogeneity of "major depression".
World Psychiatry. 2011 Oct;10(3):226-8. doi: 10.1002/j.2051-5545.2011.tb00061.x.
2
Causes and Consequences of Diagnostic Heterogeneity in Depression: Paths to Discovering Novel Biological Depression Subtypes.
Biol Psychiatry. 2020 Jul 1;88(1):83-94. doi: 10.1016/j.biopsych.2020.01.012. Epub 2020 Jan 28.
3
Simultaneous Decomposition of Depression Heterogeneity on the Person-, Symptom- and Time-Level: The Use of Three-Mode Principal Component Analysis.
PLoS One. 2015 Jul 15;10(7):e0132765. doi: 10.1371/journal.pone.0132765. eCollection 2015.
4
Decomposing the heterogeneity of depression at the person-, symptom-, and time-level: latent variable models versus multimode principal component analysis.
BMC Med Res Methodol. 2015 Oct 15;15:88. doi: 10.1186/s12874-015-0080-4.
5
Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis.
Eur Psychiatry. 2007 Jan;22(1):1-8. doi: 10.1016/j.eurpsy.2006.10.008. Epub 2006 Dec 27.
6
The risk of developing major depression among individuals with subthreshold depression: a systematic review and meta-analysis of longitudinal cohort studies.
Psychol Med. 2019 Jan;49(1):92-102. doi: 10.1017/S0033291718000557. Epub 2018 Mar 13.
7
Prevalence of depression in myocardial infarction: A PRISMA-compliant meta-analysis.
Medicine (Baltimore). 2019 Feb;98(8):e14596. doi: 10.1097/MD.0000000000014596.
8
Predisposition locus for major depression at chromosome 12q22-12q23.2.
Am J Hum Genet. 2003 Dec;73(6):1271-81. doi: 10.1086/379978. Epub 2003 Nov 5.
9
Sample heterogeneity in unipolar depression as assessed by functional connectivity analyses is dominated by general disease effects.
J Affect Disord. 2017 Nov;222:79-87. doi: 10.1016/j.jad.2017.06.055. Epub 2017 Jun 27.
10
Treatment outcome variation between depression symptom combinations in the STAR*D study.
J Affect Disord. 2016 Sep 1;201:1-7. doi: 10.1016/j.jad.2016.04.050. Epub 2016 Apr 26.
引用本文的文献
1
Why are we still using the PHQ-9? A Historical Review and Psychometric Evaluation of Measurement Invariance.
Psychiatr Q. 2025 Sep 3. doi: 10.1007/s11126-025-10208-9.
2
A Phenomenological Reappraisal of Dynamical Systems in Psychopathology.
Psychopathology. 2025 Aug 18:1-21. doi: 10.1159/000548025.
3
A heterotrimeric G protein (Gsα) biomarker may predict antidepressant response in subjects with major depressive disorder.
Front Psychiatry. 2025 Jul 18;16:1619243. doi: 10.3389/fpsyt.2025.1619243. eCollection 2025.
4
The dietary ligands, omega-3 fatty acid endocannabinoids and short-chain fatty acids prevent cytokine-induced reduction of human hippocampal neurogenesis and alter the expression of genes involved in neuroinflammation and neuroplasticity.
Mol Psychiatry. 2025 Jul 16. doi: 10.1038/s41380-025-03119-5.
5
Biomarkers associated with treatment outcome in young people with depression: A systematic review.
Neurosci Appl. 2024 Jul 2;3:104082. doi: 10.1016/j.nsa.2024.104082. eCollection 2024.
6
Heart rate variability during inpatient treatment of depression.
J Mood Anxiety Disord. 2024 Feb 28;6:100059. doi: 10.1016/j.xjmad.2024.100059. eCollection 2024 Jun.
7
Evaluating the necessity of booster sessions in relapse prevention for depression: a longitudinal study.
Front Psychol. 2025 Jun 24;16:1568141. doi: 10.3389/fpsyg.2025.1568141. eCollection 2025.
8
Altered static and dynamic functional connectivity in major depressive disorder accompanied by high anxiety: evidence from the REST-meta-MDD consortium.
Front Psychiatry. 2025 Jun 9;16:1539702. doi: 10.3389/fpsyt.2025.1539702. eCollection 2025.
9
Chronic, combinatorial targeting of NMDARs and 5-HTRs exerts extended behavioral effects against stress-induced perseverative behavior and hyponeophagia.
Neuropsychopharmacology. 2025 Apr 22. doi: 10.1038/s41386-025-02107-1.
10
The social-ecological model of depressive symptoms in middle aged in China: a network analysis.
BMC Public Health. 2025 Apr 17;25(1):1451. doi: 10.1186/s12889-025-22699-z.
本文引用的文献
1
Enhanced care by generalists for functional somatic symptoms and disorders in primary care.
Cochrane Database Syst Rev. 2013 Oct 18;2013(10):CD008142. doi: 10.1002/14651858.CD008142.pub2.
2
The detection and treatment of depression in the physically ill.
World Psychiatry. 2010 Feb;9(1):16-20. doi: 10.1002/j.2051-5545.2010.tb00256.x.
3
Deconstructing major depression: a validation study of the DSM-IV symptomatic criteria.
Psychol Med. 2010 Oct;40(10):1679-90. doi: 10.1017/S0033291709992157. Epub 2010 Jan 11.
4
Classification of anxiety and depressive disorders: problems and solutions.
Depress Anxiety. 2008;25(4):274-81. doi: 10.1002/da.20489.
5
Diagnosing major depressive disorder X: can the utility of the DSM-IV symptom criteria be improved?
J Nerv Ment Dis. 2006 Dec;194(12):893-7. doi: 10.1097/01.nmd.0000248970.50265.34.
6
Diagnosing major depressive disorder VIII: are some symptoms better than others?
J Nerv Ment Dis. 2006 Oct;194(10):785-90. doi: 10.1097/01.nmd.0000240222.75201.aa.
7
Changes in depression awareness and attitudes in Australia: the impact of beyondblue: the national depression initiative.
Aust N Z J Psychiatry. 2006 Jan;40(1):42-6. doi: 10.1080/j.1440-1614.2006.01739.x.
8
Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial.
Br J Psychiatry. 2004 Jul;185:46-54. doi: 10.1192/bjp.185.1.46.
9
Heritability of individual depressive symptoms.
J Affect Disord. 2004 Jun;80(2-3):125-33. doi: 10.1016/S0165-0327(03)00108-3.
10
Delivering interventions for depression by using the internet: randomised controlled trial.
BMJ. 2004 Jan 31;328(7434):265. doi: 10.1136/bmj.37945.566632.EE. Epub 2004 Jan 23.
Zotero 插件